http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-2764699-T3
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_37255571cfd2764f95390bdf7ff470a9 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7105 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-713 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-113 |
| filingDate | 2011-03-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2020-06-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_958fc80bdab2bbf71a3179cd6ebc6ea8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fc6dc75e49937855a6028e1ffb255493 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b32f2efd2a70427bc05d68bb5dfdf385 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_28ee2ee8ab63988051a470ee56fa6ebd http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_edc3446a44bf16e4e34ac1050617e696 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5a8a3243f2dd318834134949ffce9920 |
| publicationDate | 2020-06-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | ES-2764699-T3 |
| titleOfInvention | MiRNA molecule defined by its source and its diagnostic and therapeutic uses in diseases or conditions associated with TEM |
| abstract | MiRNA-520f molecule or mimetic or isomiR thereof, or source thereof, wherein said source of said miRNA molecule or mimetic or isomiR thereof comprises at least 80 nucleotides and comprises a motif with at least 98% of identity with SEQ ID NO: 1, or composition comprising said miRNA-520f molecule, mimetic or isomiR or source thereof, for use in the treatment, reversal, cure and / or delay of a cancer associated with TEM by inducing a TME process, where said miRNA-520f molecule comprises at least 6 of the 7 nucleotides present in the seed sequence identified as SEQ ID NO: 104 or 105 and / or has at least 80%, 81%, 82%, 83%, 84%, 85%, 86%, 87%, 88%, 89%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97% , 98%, 99% or 100% identity with SEQ ID NO: 19, 118 and / or 119 and has a length of at least 6, 7, 8, 9, 10, 11, 12, 13, 14, 15 , 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 4 0 nucleotides or more. |
| priorityDate | 2010-03-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 3216.